Summary
Gilead Sciences, Inc. (GILD) filed an 8-K on February 4, 2019, to announce its financial results for the quarter and year ended December 31, 2018. The report primarily directs investors to a press release (Exhibit 99.1) containing detailed financial information, including both GAAP and non-GAAP metrics. Management utilizes non-GAAP measures for internal operational and financial planning, believing them to be a useful supplement for investors to understand the company's performance. Investors should note that the non-GAAP financial information presented may differ from measures used by other companies and is not a substitute for GAAP-based reporting. A reconciliation between GAAP and non-GAAP figures is available within the press release. The filing itself serves as notification of the release of these results, with the actual financial data detailed in the accompanying press release.
Key Highlights
- 1Gilead Sciences announced its Q4 and full-year 2018 financial results via press release on February 4, 2019.
- 2The 8-K filing serves to furnish the press release as an exhibit.
- 3Financial results are presented on both a GAAP and non-GAAP basis.
- 4Gilead's management uses non-GAAP financial information for internal operational and financial planning.
- 5Management believes non-GAAP information is useful for investors as a supplement to GAAP results.
- 6A reconciliation between GAAP and non-GAAP financial measures is provided within the press release.
- 7The information in this 8-K and exhibit is not deemed 'filed' for certain SEC purposes.